Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

anti-microbial activity; anti-biofilm activity; Cannabis sativa L.; endocannabinoids; gut microbiota; pathogens; phytocannabinoids; synovial fibroblast; rheumatoid arthritis; cannabis; tetrahydrocannabinol; cytokines; calcium; PBMC; cannabinoid receptors; TRPA1; 2-hydroxy oleic acid; anandamide; anti Bcl2; endocannabinoid system; membrane lipid therapy; neuroblastoma; N-arachidonoylethanolamine; cortisol; chronic pain; injury; autism spectrum disorder; cannabinoids; cannabidiol; clinical trials; randomized controlled; sleep; child psychiatry; developmental disorders; rat; post-traumatic stress disorder (PTSD); URB597; mGluR5; CB1 receptor; fatty acid amide hydrolase (FAAH); β-catenin; cannabinoid; immune; macrophage; elderly; inflammatory bowel disease; D9 tetrahydrocannabinol; nitric oxide; epilepsy; animal model; cognitive dysfunction; zebrafish; ∆9-tetrahydrocannabinol; THC; CBD; prefrontal cortex; striatum; BDNF; aging; age-related diseases; neuropathic pain; anxiety; inhalation; HRQoL; phytochemistry; terpenes; synergy; entourage effect; biosynthesis; HIV; cannabidiol (CBD); tetrahydrocannabinol (THC); chronic liver diseases; quality of life; pilot clinical trial; MMP-2; MMP-9; VSMC; H9c2 cells; glucose; cell proliferation; apoptosis; cardiovascular disease; FAAH inhibitors; MGL inhibitors; neonatal brain injury; hypoxia–ischemia; neuroprotection; neurogenesis; inflammation; bile acids; transcriptomics; estrogen deficiency; ovariectomized mice; postmenopause; gut organoids; ghrelin; GHSR signaling; late adolescence; medical cannabis; polypharmacy; n/a